University of Alabama at Birmingham, Department of Pathology, Birmingham 35294, USA.
University of Alabama at Birmingham, Department of Pathology, Birmingham 35294, USA.
Matrix Biol. 2019 Jan;75-76:160-169. doi: 10.1016/j.matbio.2017.10.007. Epub 2017 Oct 26.
Emergence of the field of exosome biology has opened an exciting door to better understand communication between cells. These tiny nanovesicles act as potent regulators of biological function by delivering proteins, lipids and nucleic acids from the cell of origin to target cells. Recently, several enzymes including membrane-type 1 matrix metalloproteinase (MT1-MMP), insulin-degrading enzyme (IDE), sialidase and heparanase, among others, were localized on the surface of exosomes secreted by various cell types. These exosomal surface enzymes retain their activity and can degrade their natural substrates present within extracellular spaces. To date, enzymes on exosome surfaces have been associated with the mobilization of growth factors, degradation of extracellular matrix macromolecules and destruction of amyloid β plaques. This review focuses on the emerging role of exosomal surface enzymes and how this mechanism of remodeling within the extracellular space may regulate disease progression as related to cancer, inflammation and Alzheimer's disease.
外泌体生物学领域的出现为更好地理解细胞间的通讯开辟了令人兴奋的途径。这些微小的纳米囊泡通过将蛋白质、脂质和核酸从起源细胞传递到靶细胞,充当生物功能的有效调节剂。最近,几种酶,包括膜型 1 基质金属蛋白酶(MT1-MMP)、胰岛素降解酶(IDE)、唾液酸酶和肝素酶等,被定位在各种细胞类型分泌的外泌体表面。这些外泌体表面的酶保留其活性,并可降解细胞外空间中存在的天然底物。迄今为止,外泌体表面的酶与生长因子的动员、细胞外基质大分子的降解以及淀粉样β斑块的破坏有关。本文综述了外泌体表面酶的新作用,以及细胞外空间重塑的这种机制如何调节与癌症、炎症和阿尔茨海默病相关的疾病进展。